胸部CT评估的合并症与COPD患者全因死亡风险:BODE队列研究
该研究在379例轻至重度COPD患者中回顾性确定10种胸部CT评估的合并症基线患病率,并与临床诊断比较,随访中位78个月分析其与全因死亡的关系。冠状动脉钙化、肺气肿和支气管扩张最常见(79.8%、62.7%、33.9%),且均被低估诊断。冠状动脉钙化、支气管扩张和低腰大肌密度独立关联全因死亡。
要点
- 冠状动脉钙化、肺气肿和支气管扩张是COPD患者最常见的CT合并症。
- 多数CT诊断的合并症在临床中被低估。
- 冠状动脉钙化、支气管扩张和低腰大肌密度独立预测全因死亡。
核心结论
- 系统检测10种CT诊断的合并症可提供对患者和临床医生有潜在价值的信息,其中多数合并症临床未检测到。
研究设计与样本
- 回顾性研究,纳入379例(71%男性)轻至重度COPD门诊患者,基线确定10种CT评估的合并症,随访中位78个月。
主要发现
- 冠状动脉钙化、肺气肿和支气管扩张的患病率分别为79.8%、62.7%和33.9%,均低于CT诊断。
- 冠状动脉钙化与全因死亡独立相关(HR 2.09;95%CI 1.03-4.26,p=0.042)。
- 支气管扩张与全因死亡独立相关(HR 2.12;95%CI 1.05-4.26,p=0.036)。
- 低腰大肌密度与全因死亡独立相关(HR 2.61;95%CI 1.23-5.57,p=0.010)。
临床怎么用
- 对COPD患者进行胸部CT系统评估合并症,有助于识别临床未诊断但影响预后的情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: The availability of chest computed tomography (CT) imaging can help diagnose comorbidities associated with chronic obstructive pulmonary disease (COPD). Their systematic identification and relationship with all-cause mortality have not been explored. Furthermore, whether their CT-detected prevalence differs from clinical diagnosis is unknown. METHODS: The prevalence of 10 CT-assessed comorbidities was retrospectively determined at baseline in 379 patients (71% men) with mild to severe COPD attending pulmonary clinics. Anthropometrics, smoking history, dyspnoea, lung function, exercise capacity, BODE (BMI, Obstruction, Dyspnoea and Exercise capacity) index and exacerbations rate were recorded. The prevalence of CT-determined comorbidities was compared with that recorded clinically. Over a median of 78 months of observation, the independent association with all-cause mortality was analysed. A 'CT-comorbidome' graphically expressed the strength of their association with mortality risk. RESULTS: Coronary artery calcification, emphysema and bronchiectasis were the most prevalent comorbidities (79.8%, 62.7% and 33.9%, respectively). All were underdiagnosed before CT. Coronary artery calcium (hazard ratio [HR] 2.09; 95% CI 1.03-4.26, p = 0.042), bronchiectasis (HR 2.12; 95% CI 1.05-4.26, p = 0.036) and low psoas muscle density (HR 2.61; 95% CI 1.23-5.57, p = 0.010) were independently associated with all-cause mortality and helped define the 'CT-comorbidome'. CONCLUSION: This study of COPD patients shows that systematic detection of 10 CT-diagnosed comorbidities, most of which were not detected clinically, provides information of potential use to patients and clinicians caring for them.
引用
- Ezponda A, Casanova C, Divo M, et al. Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort. Respirology. 2022. PMID: 35132732. doi:10.1111/resp.14223
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。